In response to USDA-FSIS’s proposed regulatory framework for Salmonella in raw poultry products, Consumer Reports has called the agency’s suggested enforceable standards “too lax,” and suggests specific changes, such as including S. Infantis as a serotype of public health concern.
A recent study has demonstrated that millions of nano- and microplastics are released by polymer-based commercial tea bags when infused with hot water, and that these plastic particles are readily taken up by human intestinal cells.
USDA-FSIS has completed swine and poultry line speed studies, finding that workers experienced pain in their upper extremities. FSIS is extending the current swine and poultry line speed waivers for companies that participated in these studies through May 15, 2025.
In response to external pressures, FDA has revoked its authorization for the use of red dye 3 in food. Despite its decision, the agency maintains that the available scientific information does not support claims of the colorant being harmful to human health through dietary exposure.
Uncovered through a FOIA request, an FDA Form 483 sent to Taylor Farms’ Colorado Springs facility documented questionable food safety and hygiene observations. The release of the FOIA-requested form comes from increased scrutiny following the facility's implication as the supplier of McDonald’s onions that caused an E. coli outbreak in late 2024.
Per the USDA-FSIS Annual Plan for Fiscal Year 2025, the agency will focus on its proposed framework for Salmonella in poultry, including its regulation of Salmonella as an adulterant in certain products. FSIS will also work on truthful labeling, modernizing laboratory methods, and other efforts.
The Singapore Food Safety and Security Bill has passed Parliament, aiming to consolidate and standardize under one piece of legislation relevant food laws, as well as to modernize Singapore’s food safety regulatory system and strengthen its food chain resilience.
USDA-FSIS published a summary of its review of the deadly Boar’s Head Listeria monocytogenes outbreak, along with newly announced long-term measures to review and modernize its L. monocytogenes regulations and ready-to-eat (RTE) sampling programs.
The U.S. Food and Drug Administration (FDA) has published a Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market, building upon actions taken by the agency and implementing learnings from research conducted since the 2022 infant formula supply crisis.
RSS
